Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

WIN 2015 hosts 'world class leaders' in personalised therapy

Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA

WIN 2015 hosts 'world class leaders' in personalised therapy ( Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA )

WIN 2015: Oncologists and industry working together for personalised medicine

Prof Razelle Kurzrock - University of California, San Diego, USA

WIN 2015: Oncologists and industry working together for personalised medicine ( Prof Razelle Kurzrock - University of California, San Diego, USA )

New approaches to diffuse large B-cell lymphoma

Dr Andrew Davies - University Hospital Southampton NHS Foundation Trust...

New approaches to diffuse large B-cell lymphoma ( Dr Andrew Davies - University Hospital Southampton NHS Foundation Trust, Southampton, UK )

Comment: Metastatic triple-negative breast cancer responds to immunotherapy

Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA

Comment: Metastatic triple-negative breast cancer responds to immunotherapy ( Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA )

Comment: Research developments stir hopes for melanoma

Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA

Comment: Research developments stir hopes for melanoma ( Dr Louis Weiner - Lombardi Comprehensive Cancer Center, Washington D.C, USA )

Certain classes of genes in patients that could lead to prostate cancer

Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA

Certain classes of genes in patients that could lead to prostate cancer ( Dr Erica Golemis - Fox Chase Cancer Center, Philadelphia, USA )

New T cell–based immunotherapy shows promise for lethal stem cell transplant...

Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication ( Dr Susan Prockop - Memorial Sloan Kettering Cancer Center, New York, USA )

Investigational PD-L1–targeted immunotherapy safe for patients with triple...

Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA

Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer ( Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )

Pembrolizumab found to be safe with durable responses in advanced non-small...

Dr Edward Garon - David Geffen School of Medicine at the University of...

Pembrolizumab found to be safe with durable responses in advanced non-small cell lung cancer ( Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA )

PARP inhibitor combo shows early promise for patients with and without BRCA...

Dr Timothy Yap - Royal Marsden Hospital, London, UK

PARP inhibitor combo shows early promise for patients with and without BRCA mutations ( Dr Timothy Yap - Royal Marsden Hospital, London, UK )

Phase III trial shows pembrolizumab preferable to ipilimumab in advanced...

Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA

Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanoma ( Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )

Long-term, regular aspirin use modestly decreased cancer risk

Prof Andrew Chan - Harvard Medical School and Massachusetts General Hospital...

Long-term, regular aspirin use modestly decreased cancer risk ( Prof Andrew Chan - Harvard Medical School and Massachusetts General Hospital, Boston USA )

More from ecancer